Download FREE Report Sample
Download Free sampleNicotinamide Phosphoribosyltransferase Market contains market size and forecasts of Nicotinamide Phosphoribosyltransferase in global, including the following market information:
Global Nicotinamide Phosphoribosyltransferase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nicotinamide Phosphoribosyltransferase Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Nicotinamide Phosphoribosyltransferase companies in 2021 (%)
The global Nicotinamide Phosphoribosyltransferase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nicotinamide Phosphoribosyltransferase include Genentech, Inc., Angelini Group, Calico LLC, FORMA Therapeutics, Inc., OncoTartis, Inc., Karyopharm Therapeutics, Inc. and Aurigene Discovery Technologies Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nicotinamide Phosphoribosyltransferase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nicotinamide Phosphoribosyltransferase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nicotinamide Phosphoribosyltransferase Market Segment Percentages, by Type, 2021 (%)
Hormone
Lipids
Small Molecule Compounds
Others
Global Nicotinamide Phosphoribosyltransferase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nicotinamide Phosphoribosyltransferase Market Segment Percentages, by Application, 2021 (%)
Parkinson's Disease
Acute Lung Injury
Breast Cancer
Others
Global Nicotinamide Phosphoribosyltransferase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nicotinamide Phosphoribosyltransferase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nicotinamide Phosphoribosyltransferase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nicotinamide Phosphoribosyltransferase revenues share in global market, 2021 (%)
Key companies Nicotinamide Phosphoribosyltransferase sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Nicotinamide Phosphoribosyltransferase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
